Literature DB >> 17655926

Time course of the hypothermic response to continuously administered neurotensin.

Erik Popp1, Andreas Schneider, Peter Vogel, Peter Teschendorf, Bernd W Böttiger.   

Abstract

Intracerebroventricular administration of the tridecapeptide neurotensin is known to elicit hypothermia in rodents for few hours. In the present study, we investigated a continuous intracerebroventricular infusion regimen for prolongation of the hypothermic effect. Male Wistar-Han rats (n=13) received neurotensin 10-50 microg/h for 48 h, while their body temperature was monitored continuously. This protocol led to a dose-dependent decrease of body temperature down to 35-36 degrees C. The nadir of hypothermia lasted for approximately 4h and normothermia was re-established after 12-24h. Furthermore, abundance of neurotensin in the hypothalamus was determined after 6 and 30 h by western blotting. High levels were still found at 30 h, while the rats had already become normothermic at that time. In summary, continuous infusion of neurotensin led to prolongation of the known hypothermic response, however resulted in development of tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17655926     DOI: 10.1016/j.npep.2007.06.002

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  8 in total

1.  The role of NTS2 in the development of tolerance to NT69L in mouse models for hypothermia and thermal analgesia.

Authors:  Kristin E Smith; Mona Boules; Katrina Williams; Abdul H Fauq; Elliott Richelson
Journal:  Behav Brain Res       Date:  2011-06-21       Impact factor: 3.332

2.  Conjugation of a brain-penetrant peptide with neurotensin provides antinociceptive properties.

Authors:  Michel Demeule; Nicolas Beaudet; Anthony Régina; Élie Besserer-Offroy; Alexandre Murza; Pascal Tétreault; Karine Belleville; Christian Ché; Alain Larocque; Carine Thiot; Richard Béliveau; Jean-Michel Longpré; Éric Marsault; Richard Leduc; Jean E Lachowicz; Steven L Gonias; Jean-Paul Castaigne; Philippe Sarret
Journal:  J Clin Invest       Date:  2014-02-17       Impact factor: 14.808

3.  Neurotensin and its receptors in the control of glucose homeostasis.

Authors:  Jean Mazella; Sophie Béraud-Dufour; Christelle Devader; Fabienne Massa; Thierry Coppola
Journal:  Front Endocrinol (Lausanne)       Date:  2012-11-26       Impact factor: 5.555

4.  Drug-induced mild therapeutic hypothermia obtained by administration of a transient receptor potential vanilloid type 1 agonist.

Authors:  Keld Fosgerau; Uno J Weber; Jacob W Gotfredsen; Magdalena Jayatissa; Carsten Buus; Niels B Kristensen; Mogens Vestergaard; Peter Teschendorf; Andreas Schneider; Philip Hansen; Jakob Raunsø; Lars Køber; Christian Torp-Pedersen; Charlotte Videbaek
Journal:  BMC Cardiovasc Disord       Date:  2010-10-09       Impact factor: 2.298

Review 5.  To ingest or rest? Specialized roles of lateral hypothalamic area neurons in coordinating energy balance.

Authors:  Juliette A Brown; Hillary L Woodworth; Gina M Leinninger
Journal:  Front Syst Neurosci       Date:  2015-02-18

6.  Neurotensin and its high affinity receptor 1 as a potential pharmacological target in cancer therapy.

Authors:  Zherui Wu; Daniel Martinez-Fong; Jean Trédaniel; Patricia Forgez
Journal:  Front Endocrinol (Lausanne)       Date:  2013-01-17       Impact factor: 5.555

7.  The anti-apoptotic role of neurotensin.

Authors:  Christelle Devader; Sophie Béraud-Dufour; Thierry Coppola; Jean Mazella
Journal:  Cells       Date:  2013-03-04       Impact factor: 6.600

8.  Increased Brain Neurotensin and NTSR2 Lead to Weak Nociception in NTSR3/Sortilin Knockout Mice.

Authors:  Christelle Devader; Sébastien Moreno; Morgane Roulot; Emmanuel Deval; Thomas Dix; Carlos R Morales; Jean Mazella
Journal:  Front Neurosci       Date:  2016-11-24       Impact factor: 4.677

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.